(Q45097069)

9 December 2017

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients (English)

1 reference

9 December 2017

0 references

6

1 reference

PubMed ID

15472904

9 December 2017

Olli-Pekka Kallioniemi

series ordinal

11

1 reference

9 December 2017

13

1 reference

9 December 2017

12

Jiri Bartek

1 reference

9 December 2017

2

Jirina Bartkova

1 reference

9 December 2017

7

Carl Blomqvist

1 reference

9 December 2017

1

Outi Kilpivaara

1 reference

9 December 2017

9

Päivi Heikkilä

1 reference

9 December 2017

3

Hannaleena Eerola

1 reference

9 December 2017

5

Pia Vahteristo

1 reference

9 December 2017

4

Kirsi Syrjäkoski

1 reference

9 December 2017

8

Kaija Holli

1 reference

9 December 2017

Guido Sauter

10

1 reference

PubMed ID

15472904

9 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

International Journal of Cancer

9 December 2017

1 reference

9 December 2017

113

1 reference

9 December 2017

575-580

1 reference

9 December 2017

4

1 reference

Chk1 and Chk2 kinases in checkpoint control and cancer

9 December 2017

1 reference

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

Characterization of tumor-associated Chk2 mutations

21 January 2018

1 reference

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

21 January 2018

1 reference

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 January 2018

1 reference

CHEK2 variant I157T may be associated with increased breast cancer risk.

21 January 2018

1 reference

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

21 January 2018

1 reference

CHEK2 variants associate with hereditary prostate cancer

21 January 2018

1 reference

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

21 January 2018

1 reference

Concomitant inactivation of p53 and Chk2 in breast cancer

21 January 2018

1 reference

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

21 January 2018

1 reference

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers.

21 January 2018

1 reference

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

21 January 2018

1 reference

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.20638

1 reference

9 December 2017

1 reference

PubMed ID

15472904